Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluououracil + levamisole for adjuvant therapy of resected colon carcinoma

British Journal of Cancer

Volumn 77, Issue 8, 1998, Pages 1349-1354

  Scheithauer, W ^a   Kornek, G V ^a   Marczell, A ^b   Karner, J ^c   Salem, G ^d   Greiner, R ^d   Burger, D ^e   Stoger F ^f   Ritschel, J ^f   Kovats, E ^g   Vischer, H M ^h   Schneeweiss, B ^h   Depisch, D ^h  

^a UNIVERSITY OF VIENNA   (Austria)

^b HANUSCH HOSPITAL   (Austria)

^c KAISER FRANZ JOSEF HOSPITAL   (Austria)

^d General Hospital St Poelten   (Austria)

^e KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

^f General Hospital Tulln   (Austria)

^g NONE   (Austria)

^h NONE   (Austria)

Author keywords

Adjuvant therapy; Colon carcinoma; Fluorouracil; Intraperitoneal chemotherapy; Leucovorin; Levamisole

Indexed keywords

FLUOROURACIL; FOLINIC ACID; LEVAMISOLE;

ABDOMINAL PAIN; ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COLON CARCINOMA; CONJUNCTIVITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DIARRHEA; FEMALE; GRANULOCYTOPENIA; HUMAN; INFECTION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; LIVER DYSFUNCTION; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROTOXICITY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMATITIS; THROMBOCYTOPENIA; VOMITING;

EID: 6844226189     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.225     Document Type: Article

References (31)

1. Advanced Colorectal Cancer Meta-Analysis Project (1992) Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 10: 896-903
2. Buroker TR, Moertel CG, Fleming TR, Everson LK, Cullinan SA and Krook JE (1985) A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma. J Clin Oncol 3: 1624-1631
3. Cohen AM, Minsky BD and Sehilsky RL (1993) Colon cancer. In Cancer: Principles and Practice of Oncology 4th edn. De Vita VT. Jr, Hellman S. Rosenberg SA (eds). pp. 929-977. Lippincott: Philadelphia
4. Cox DR (1472) Regression models and life-tables. J R Stat Soc (B) 34: 187-220
5. Cunliffe WJ and Sugarbaker PH (1989) Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitonal chemotherapy. Br J Surg 76: 1082-1090
6. Delorenzo L and Stewart JA (1990) Levamisole toxicity (letter). J Clin Oncol 8: 365
7. Francini G, Petrioli R, Lorenzini L, Mancini S, Armenio S, Tanzini G, Marsili S, Aquino A, Marzocca G, Civitelli S, Mariani L, DeSando D, Bovenga S and Lorenzi M (1994) Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer, Gastroenterology 106: 899-906.
8. IMPACT Trial (1995) Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet 345: 939-944
9. Kaplan LK and Meier P (1958) Nonparametric estimation from incomplete observations. Am J Stat Assoc 53: 457-481
10. Köhne-Wömpner CH, Schöffski P and Schmoll HJ (1994) Adjuvant therapy for colon adenocarcinoma: current status of clinical investigation. Ann Oncol 5 (suppl. 3): 97-104
11. Latter UT and Metzger U (1995) Intraportal chemotherapy for colorectal hepatic metastases. World J Surg 19: 246-251
12. Laurie JA, Moertel CG, Fleming TR, Wieand HS, Leigh JE, Rubin J, McCormack GW, Gerstner JB, Krook JE, Malliard J, Twito DI, Morton RF, Tschetter LK and Barlow JF (1989) Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. J Clin Oncol 7: 1447-1456
13. Mantel H and Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
14. Miller AB, Hoogstraten B and Staquet M (1981) Reporting results of cancer treatment. Cancer 47: 207-214
15. Moertel CG, Fleming TR, MacDonald JS, Haller DG, Laurie JA, Goodman PJ, Ungerleider JS, Emerson WA, Tormey DC, Glick JH, Veeder MH and Mailliard JA (1991) Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 322: 352-358
16. Moertel CG, Fleming TR, MacDonald JS, Haller DG, Laurie JA, Tangen CM, Ungerleider JS, Emerson WA, Tormey DC and Glick JH (1995) Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 122: 321-326
17. NIH Consensus Conference on Adjuvant Therapy for Patients with Colon and Rectal Cancer (1990) J Am Med Assoc 264: 1444-1450
18. Nordlinger B, Bouteloup PY and Favre JP (1990) Early post-operative intraperitoneal chemotherapy is feasible and well tolerated in colon cancer. A prospective randomised study (abstract). J Cancer Res Clin Oncol 116: 686
19. O'Connell MJ, Laurie JA, Shepherd L, Kahn MJ, Pazdur R, Fitzgibbons RJ, Erlichman HS and Wieand HS (1996) A prospective evaluation of chemotherapy duration and regimen as surgical adjuvant treatment for highrisk colon cancer: a collaborative trial of the North Central Cancer Treatment Group and the National Cancer Institute of Canada Clinical Trials (abstract). Proc Am Soc Clin Oncol 15: 209
20. O'Connell MJ, Mailliard JA, Kahn MJ, Macdonald JS, Haller DG, Mayer RJ and Wieand HS (1997) Controlled trial of fluorouracil and low-dose lencovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 15: 246-250
21. Reynolds T (1995) Dutch trial casts doubt on colorectal adjuvant therapy. J Natl Cancer Inst 87: 476-479
22. Rougier P and Nordlinger B (1993) Large scale trial for adjuvant treatment in high risk resected colorectal cancers: rationale to lest the combination of locoregional and systemic chemotherapy and to compare I-leucovorin + 5-FU to levamisole + 5-FU. Ann Oncol 4: (suppl.2): 21-28
23. Scheithauer W, Kornek G, Rosen H, Sebesta C, Marczell A, Kwasny W, Karall M and Depisch D (1995) Combined intraperitoneal plus intravenous chemotherapy after curative resection for colonic adenocarcinoma. Eur. J Cancer 31A: 1981-1986
24. Speyer LS (1985) The rationale behind intraperitoneal chemotherapy in gastrointestinal malignancies. Semin Oncol 12: 23-28
25. Sugarbaker PH, Gianola FJ, Speyer JC, Wesley R, Barofsky I and Meyers CE (1985) Prospective randomised trial of intravenous versus intraperitoneal 5-fluorouracil in patients with advanced primary colon or rectal cancer. Surgery 98: 414-421
26. Sugarbaker PH, Schellinx MET, Chang D, Koslowe P and Meyerfeldt M (1996) Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg 20: 585-592
27. Wassner A and Heidemann E (1996) Levamisole and 5-fluorouracil as an adjuvant therapy for patients after curative resection of colon carcinoma Dukes' stage C (TNM III): more disadvantages than advantages. Onkologie 19: 140-145
28. Wolmark N, Rockette H, Fisher B, Wickerham DL, Redmond C, Fisher ER, Jones J, Mamounas EP, Ore L, Petrelli NJ, Spurr CL, Dimitrov N, Romond EH, Sutherland CM, Kardinal CG, DeFusco PA and Jochimsen P (1993) The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-03. J Clin Oncol 11: 1879-1887
29. Wolmark N, Rockette H, Mamounas EP, Jones J, Petrelli N, Atkins J, Dimitrov N, Pugh R, Wickerham DL, Wieand S and Fisher B (1996) The relative efficacy of 5-FU + leucovorin (FU-LV), 5-FU + levamisole (FU-LEV), and 5-FU + leucovorin + levamisole (FU-LV-LEV) in patients with Dukes' B and C carcinoma of the colon: first report of NSABP C-04 (abstract). Proc Am Soc Clin Oncol 15: 205
30. Zalcberg JR, Siderov J and Simes J on behalf of the Australasian Gastrointestinal Trials Group (1996) The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer. Ann Oncol 7: 41-46
31. Zelen M (1979) A new design for randomised clinical trials. N Engl J Med 300: 1242-1245